Characterization of the Maternally Derived Antibody Immunity against Rhdv-2

Startseite Know-how Characterization of the Maternally Derived Antibody Immunity against Rhdv-2

Characterization of the Maternally Derived Antibody Immunity against Rhdv-2

The aim of this study was to test whether an inactivated vaccine indicated for active immunization of adult rabbits can produce a passive antibody immunity in blood against RHDV-2 in rabbit kits.

Über diesen Artikel

Veröffentlicht in

MDPI Vaccines, 2020

Datum

28.08.2020

Verfasser

Baratelli, M.; Molist-Badiola, J.; Puigredon-Fontanet, A.; Pascual, M.; Boix, O.; Mora-Igual, F.X.; Woodward, M.; Lavazza, A.; Capucci, L.

Zusammenfassung

The present study demonstrated that an inactivated vaccine designed for active immunization of adult rabbits can produce a passive antibody immunity against RHDV-2 in rabbit kits without implementing a tailor-made administration program. Moreover, the produced immunity is likely to cover the early life of rabbits at least until they turn suitable to be vaccinated (older than 30 days of life).

Ähnliche Produkte

Teilen

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}